O'Shaughnessy Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRWD
AC
SCM
VPM
VCM
O'Shaughnessy Asset Management's IRWD Position: Q1 2026 in Review
O'Shaughnessy Asset Management reduced its Ironwood Pharmaceuticals (IRWD) stake by 56% in Q1 2026, selling an estimated $664K and leaving 128,243 shares worth $450K. The position accounts for ﹤0.01% of the portfolio, ranked #1578.
O'Shaughnessy Asset Management first reported a position in IRWD in Q2 2020 and has held it in 18 quarters since. The position peaked at $1.58M in Q4 2022. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.
- O'Shaughnessy Asset Management held 128,243 shares of Ironwood Pharmaceuticals worth $450K as of Q1 2026.
- O'Shaughnessy Asset Management sold 162,035 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $664K.
- Ironwood Pharmaceuticals made up ﹤0.01% of O'Shaughnessy Asset Management's portfolio in Q1 2026, its #1578 holding.
- O'Shaughnessy Asset Management first reported a position in Ironwood Pharmaceuticals in Q2 2020 and has held it in 18 quarters since.
- O'Shaughnessy Asset Management's Ironwood Pharmaceuticals position peaked at $1.58M in Q4 2022.
- 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.
Based on O'Shaughnessy Asset Management's 13F filing for Q1 2026, filed 13 May 2026.